esophageal cancer
Previse Ramps up Commercialization of Barrett's Esophagus Test, Developing Esophageal Cancer Assay
Premium
The company currently offers a risk stratification test for Barrett's esophagus and is developing an early detection test for esophageal cancer.
The company reported that its Barrett's esophagus risk assay saw volumes more than triple in Q3 2023 compared to the same period last year.
Previse Wins $1.8M NIH Grant to Help Advance Esophageal Cancer Risk PCR Test
The funding will be used in part to clinically validate the lab-developed test, which measures DNA methylation to determine a Barrett's esophagus patient's risk of developing cancer.
Esophageal Cancer Susceptibility Risk Variants Found in South African Population
Using GWAS data, researchers identified esophageal squamous cell carcinoma risk variants that overlap with those found in a high-risk population in China.
Findings from two clinical studies were reported at Digestive Disease Week earlier this month that supported use of the firm's EsoCheck device and EsoGuard test.